APO Research
Talk to an analyst

APO RESEARCH · REPORT

Male Infertility

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Male Infertility Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchMale Infertility Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Male Infertility Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Male Infertility Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Male Infertility Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Male Infertility Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Male Infertility market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Male Infertility is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Male Infertility is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Male Infertility is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Male Infertility is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Male Infertility include CCRM, Male Infertility, Monash IVF, The Cooper, Ferring Pharmaceuticals, Merck & Co and Thermo Fisher, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Male Infertility, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Male Infertility, also provides the revenue of main regions and countries. Of the upcoming market potential for Male Infertility, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Male Infertility revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Male Infertility market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Male Infertility revenue, projected growth trends, production technology, application and end-user industry.

Male Infertility Segment by Company

CCRM

Male Infertility

Monash IVF

The Cooper

Ferring Pharmaceuticals

Merck & Co

Thermo Fisher

Male Infertility Segment by Type

ART

Fertility Drugs

Fertility Surgery

Artificial Insemination

Others

Male Infertility Segment by Application

Fertility Clinics

Research Banks

Hospitals

Male Infertility Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Male Infertility market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Male Infertility and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Male Infertility.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Male Infertility in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Male Infertility company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Male Infertility revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Male Infertility Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ART Major Player Table 3. Fertility Drugs Major Player Table 4. Fertility Surgery Major Player Table 5. Artificial Insemination Major Player Table 6. Others Major Player Table 7. Global Male Infertility Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Fertility Clinics Major Player Table 9. Research Banks Major Player Table 10. Hospitals Major Player Table 11. Male Infertility Industry Trends Table 12. Male Infertility Industry Drivers Table 13. Male Infertility Industry Opportunities and Challenges Table 14. Male Infertility Industry Restraints Table 15. Global Male Infertility Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Male Infertility Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Male Infertility Market Share by Region (2021-2026) Table 18. Global Male Infertility Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Male Infertility Market Share by Region (2027-2032) Table 20. Global Male Infertility Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Male Infertility Revenue Market Share by Players (2021-2026) Table 22. Global Male Infertility Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Male Infertility Key Players Headquarters & Area Served Table 24. Global Male Infertility Players, Product Type & Application Table 25. Global Male Infertility Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Male Infertility by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Male Infertility Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Male Infertility Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Male Infertility Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Male Infertility Revenue Market Share by Type (2021-2026) Table 32. Global Male Infertility Revenue Market Share by Type (2027-2032) Table 33. Global Male Infertility Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Male Infertility Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Male Infertility Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Male Infertility Revenue Market Share by Application (2021-2026) Table 37. Global Male Infertility Revenue Market Share by Application (2027-2032) Table 38. CCRM Company Information Table 39. CCRM Business Overview Table 40. CCRM Male Infertility Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. CCRM Male Infertility Product Portfolio Table 42. CCRM Recent Development Table 43. Male Infertility Company Information Table 44. Male Infertility Business Overview Table 45. Male Infertility Male Infertility Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Male Infertility Male Infertility Product Portfolio Table 47. Male Infertility Recent Development Table 48. Monash IVF Company Information Table 49. Monash IVF Business Overview Table 50. Monash IVF Male Infertility Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Monash IVF Male Infertility Product Portfolio Table 52. Monash IVF Recent Development Table 53. The Cooper Company Information Table 54. The Cooper Business Overview Table 55. The Cooper Male Infertility Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. The Cooper Male Infertility Product Portfolio Table 57. The Cooper Recent Development Table 58. Ferring Pharmaceuticals Company Information Table 59. Ferring Pharmaceuticals Business Overview Table 60. Ferring Pharmaceuticals Male Infertility Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Ferring Pharmaceuticals Male Infertility Product Portfolio Table 62. Ferring Pharmaceuticals Recent Development Table 63. Merck & Co Company Information Table 64. Merck & Co Business Overview Table 65. Merck & Co Male Infertility Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Merck & Co Male Infertility Product Portfolio Table 67. Merck & Co Recent Development Table 68. Thermo Fisher Company Information Table 69. Thermo Fisher Business Overview Table 70. Thermo Fisher Male Infertility Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Thermo Fisher Male Infertility Product Portfolio Table 72. Thermo Fisher Recent Development Table 73. North America Male Infertility Revenue by Type (2021-2026) & (US$ Million) Table 74. North America Male Infertility Revenue by Type (2027-2032) & (US$ Million) Table 75. North America Male Infertility Revenue by Application (2021-2026) & (US$ Million) Table 76. North America Male Infertility Revenue by Application (2027-2032) & (US$ Million) Table 77. North America Male Infertility Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. North America Male Infertility Revenue by Country (2021-2026) & (US$ Million) Table 79. North America Male Infertility Revenue by Country (US$ Million) & (2027-2032) Table 80. Europe Male Infertility Revenue by Type (2021-2026) & (US$ Million) Table 81. Europe Male Infertility Revenue by Type (2027-2032) & (US$ Million) Table 82. Europe Male Infertility Revenue by Application (2021-2026) & (US$ Million) Table 83. Europe Male Infertility Revenue by Application (2027-2032) & (US$ Million) Table 84. Europe Male Infertility Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. Europe Male Infertility Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Male Infertility Revenue by Country (US$ Million) & (2027-2032) Table 87. China Male Infertility Revenue by Type (2021-2026) & (US$ Million) Table 88. China Male Infertility Revenue by Type (2027-2032) & (US$ Million) Table 89. China Male Infertility Revenue by Application (2021-2026) & (US$ Million) Table 90. China Male Infertility Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia Male Infertility Revenue by Type (2021-2026) & (US$ Million) Table 92. Asia Male Infertility Revenue by Type (2027-2032) & (US$ Million) Table 93. Asia Male Infertility Revenue by Application (2021-2026) & (US$ Million) Table 94. Asia Male Infertility Revenue by Application (2027-2032) & (US$ Million) Table 95. Asia Male Infertility Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Asia Male Infertility Revenue by Region (US$ Million) & (2021-2026) Table 97. Asia Male Infertility Revenue by Region (US$ Million) & (2027-2032) Table 98. SAMEA Male Infertility Revenue by Type (2021-2026) & (US$ Million) Table 99. SAMEA Male Infertility Revenue by Type (2027-2032) & (US$ Million) Table 100. SAMEA Male Infertility Revenue by Application (2021-2026) & (US$ Million) Table 101. SAMEA Male Infertility Revenue by Application (2027-2032) & (US$ Million) Table 102. SAMEA Male Infertility Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. SAMEA Male Infertility Revenue by Country (2021-2026) & (US$ Million) Table 104. SAMEA Male Infertility Revenue by Country (US$ Million) & (2027-2032) Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Male Infertility Image Figure 2. Global Male Infertility Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Male Infertility Market Size Share 2021 VS 2025 VS 2032 Figure 4. ART Image Figure 5. Fertility Drugs Image Figure 6. Fertility Surgery Image Figure 7. Artificial Insemination Image Figure 8. Others Image Figure 9. Global Male Infertility Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Male Infertility Market Size Share 2021 VS 2025 VS 2032 Figure 11. Fertility Clinics Image Figure 12. Research Banks Image Figure 13. Hospitals Image Figure 14. Global Male Infertility Market Size (US$ Million) & (2021-2032) Figure 15. Global Male Infertility Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Male Infertility Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Male Infertility Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Male Infertility Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Male Infertility Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Male Infertility Revenue Market Share by Type (2021-2032) Figure 22. Global Male Infertility Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Male Infertility Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Male Infertility Revenue Market Share by Application (2021-2032) Figure 25. North America Male Infertility Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Male Infertility Revenue Share by Type (2021-2032) Figure 27. North America Male Infertility Revenue Share by Application (2021-2032) Figure 28. North America Male Infertility Revenue Share by Country (2021-2032) Figure 29. United States Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Male Infertility Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Male Infertility Revenue Share by Type (2021-2032) Figure 34. Europe Male Infertility Revenue Share by Application (2021-2032) Figure 35. Europe Male Infertility Revenue Share by Country (2021-2032) Figure 36. Germany Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Male Infertility Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Male Infertility Revenue Share by Type (2021-2032) Figure 46. China Male Infertility Revenue Share by Application (2021-2032) Figure 47. Asia Male Infertility Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Male Infertility Revenue Share by Type (2021-2032) Figure 49. Asia Male Infertility Revenue Share by Application (2021-2032) Figure 50. Asia Male Infertility Revenue Share by Region (2021-2032) Figure 51. Japan Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Male Infertility Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Male Infertility Revenue Share by Type (2021-2032) Figure 59. SAMEA Male Infertility Revenue Share by Application (2021-2032) Figure 60. SAMEA Male Infertility Revenue Share by Country (2021-2032) Figure 61. Brazil Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Male Infertility Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • ART
  • Fertility Drugs
  • Fertility Surgery
  • Artificial Insemination
  • Others
Applications
  • Fertility Clinics
  • Research Banks
  • Hospitals
Companies covered
  • CCRM
  • Male Infertility
  • Monash IVF
  • The Cooper
  • Ferring Pharmaceuticals
  • Merck & Co
  • Thermo Fisher

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Male Infertility Market by Type
  3. 1.2.1 Global Male Infertility Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ART
  5. 1.2.3 Fertility Drugs
  6. 1.2.4 Fertility Surgery
  7. 1.2.5 Artificial Insemination
  8. 1.2.6 Others
  9. 1.3 Male Infertility Market by Application
  10. 1.3.1 Global Male Infertility Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Fertility Clinics
  12. 1.3.3 Research Banks
  13. 1.3.4 Hospitals
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Male Infertility Market Dynamics
  1. 2.1 Male Infertility Industry Trends
  2. 2.2 Male Infertility Industry Drivers
  3. 2.3 Male Infertility Industry Opportunities and Challenges
  4. 2.4 Male Infertility Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Male Infertility Market Perspective (2021-2032)
  2. 3.2 Global Male Infertility Growth Trends by Region
  3. 3.2.1 Global Male Infertility Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Male Infertility Market Size by Region (2021-2026)
  5. 3.2.3 Global Male Infertility Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Male Infertility Revenue by Players
  2. 4.1.1 Global Male Infertility Revenue by Players (2021-2026)
  3. 4.1.2 Global Male Infertility Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Male Infertility Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Male Infertility Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Male Infertility Key Players Headquarters & Area Served
  7. 4.4 Global Male Infertility Players, Product Type & Application
  8. 4.5 Global Male Infertility Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Male Infertility Market CR5 and HHI
  11. 4.6.3 2025 Male Infertility Tier 1, Tier 2, and Tier 3
5 Male Infertility Market Size by Type
  1. 5.1 Global Male Infertility Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Male Infertility Revenue by Type (2021-2032)
  3. 5.3 Global Male Infertility Revenue Market Share by Type (2021-2032)
6 Male Infertility Market Size by Application
  1. 6.1 Global Male Infertility Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Male Infertility Revenue by Application (2021-2032)
  3. 6.3 Global Male Infertility Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 CCRM
  2. 7.1.1 CCRM Company Information
  3. 7.1.2 CCRM Business Overview
  4. 7.1.3 CCRM Male Infertility Revenue and Gross Margin (2021-2026)
  5. 7.1.4 CCRM Male Infertility Product Portfolio
  6. 7.1.5 CCRM Recent Developments
  7. 7.2 Male Infertility
  8. 7.2.1 Male Infertility Company Information
  9. 7.2.2 Male Infertility Business Overview
  10. 7.2.3 Male Infertility Male Infertility Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Male Infertility Male Infertility Product Portfolio
  12. 7.2.5 Male Infertility Recent Developments
  13. 7.3 Monash IVF
  14. 7.3.1 Monash IVF Company Information
  15. 7.3.2 Monash IVF Business Overview
  16. 7.3.3 Monash IVF Male Infertility Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Monash IVF Male Infertility Product Portfolio
  18. 7.3.5 Monash IVF Recent Developments
  19. 7.4 The Cooper
  20. 7.4.1 The Cooper Company Information
  21. 7.4.2 The Cooper Business Overview
  22. 7.4.3 The Cooper Male Infertility Revenue and Gross Margin (2021-2026)
  23. 7.4.4 The Cooper Male Infertility Product Portfolio
  24. 7.4.5 The Cooper Recent Developments
  25. 7.5 Ferring Pharmaceuticals
  26. 7.5.1 Ferring Pharmaceuticals Company Information
  27. 7.5.2 Ferring Pharmaceuticals Business Overview
  28. 7.5.3 Ferring Pharmaceuticals Male Infertility Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Ferring Pharmaceuticals Male Infertility Product Portfolio
  30. 7.5.5 Ferring Pharmaceuticals Recent Developments
  31. 7.6 Merck & Co
  32. 7.6.1 Merck & Co Company Information
  33. 7.6.2 Merck & Co Business Overview
  34. 7.6.3 Merck & Co Male Infertility Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merck & Co Male Infertility Product Portfolio
  36. 7.6.5 Merck & Co Recent Developments
  37. 7.7 Thermo Fisher
  38. 7.7.1 Thermo Fisher Company Information
  39. 7.7.2 Thermo Fisher Business Overview
  40. 7.7.3 Thermo Fisher Male Infertility Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Thermo Fisher Male Infertility Product Portfolio
  42. 7.7.5 Thermo Fisher Recent Developments
8 North America
  1. 8.1 North America Male Infertility Revenue (2021-2032)
  2. 8.2 North America Male Infertility Revenue by Type (2021-2032)
  3. 8.2.1 North America Male Infertility Revenue by Type (2021-2026)
  4. 8.2.2 North America Male Infertility Revenue by Type (2027-2032)
  5. 8.3 North America Male Infertility Revenue Share by Type (2021-2032)
  6. 8.4 North America Male Infertility Revenue by Application (2021-2032)
  7. 8.4.1 North America Male Infertility Revenue by Application (2021-2026)
  8. 8.4.2 North America Male Infertility Revenue by Application (2027-2032)
  9. 8.5 North America Male Infertility Revenue Share by Application (2021-2032)
  10. 8.6 North America Male Infertility Revenue by Country
  11. 8.6.1 North America Male Infertility Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Male Infertility Revenue by Country (2021-2026)
  13. 8.6.3 North America Male Infertility Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Male Infertility Revenue (2021-2032)
  2. 9.2 Europe Male Infertility Revenue by Type (2021-2032)
  3. 9.2.1 Europe Male Infertility Revenue by Type (2021-2026)
  4. 9.2.2 Europe Male Infertility Revenue by Type (2027-2032)
  5. 9.3 Europe Male Infertility Revenue Share by Type (2021-2032)
  6. 9.4 Europe Male Infertility Revenue by Application (2021-2032)
  7. 9.4.1 Europe Male Infertility Revenue by Application (2021-2026)
  8. 9.4.2 Europe Male Infertility Revenue by Application (2027-2032)
  9. 9.5 Europe Male Infertility Revenue Share by Application (2021-2032)
  10. 9.6 Europe Male Infertility Revenue by Country
  11. 9.6.1 Europe Male Infertility Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Male Infertility Revenue by Country (2021-2026)
  13. 9.6.3 Europe Male Infertility Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Male Infertility Revenue (2021-2032)
  2. 10.2 China Male Infertility Revenue by Type (2021-2032)
  3. 10.2.1 China Male Infertility Revenue by Type (2021-2026)
  4. 10.2.2 China Male Infertility Revenue by Type (2027-2032)
  5. 10.3 China Male Infertility Revenue Share by Type (2021-2032)
  6. 10.4 China Male Infertility Revenue by Application (2021-2032)
  7. 10.4.1 China Male Infertility Revenue by Application (2021-2026)
  8. 10.4.2 China Male Infertility Revenue by Application (2027-2032)
  9. 10.5 China Male Infertility Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Male Infertility Revenue (2021-2032)
  2. 11.2 Asia Male Infertility Revenue by Type (2021-2032)
  3. 11.2.1 Asia Male Infertility Revenue by Type (2021-2026)
  4. 11.2.2 Asia Male Infertility Revenue by Type (2027-2032)
  5. 11.3 Asia Male Infertility Revenue Share by Type (2021-2032)
  6. 11.4 Asia Male Infertility Revenue by Application (2021-2032)
  7. 11.4.1 Asia Male Infertility Revenue by Application (2021-2026)
  8. 11.4.2 Asia Male Infertility Revenue by Application (2027-2032)
  9. 11.5 Asia Male Infertility Revenue Share by Application (2021-2032)
  10. 11.6 Asia Male Infertility Revenue by Country
  11. 11.6.1 Asia Male Infertility Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Male Infertility Revenue by Country (2021-2026)
  13. 11.6.3 Asia Male Infertility Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Male Infertility Revenue (2021-2032)
  2. 12.2 SAMEA Male Infertility Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Male Infertility Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Male Infertility Revenue by Type (2027-2032)
  5. 12.3 SAMEA Male Infertility Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Male Infertility Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Male Infertility Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Male Infertility Revenue by Application (2027-2032)
  9. 12.5 SAMEA Male Infertility Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Male Infertility Revenue by Country
  11. 12.6.1 SAMEA Male Infertility Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Male Infertility Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Male Infertility Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst